Pretreatment of colon carcinoma cells with tomudex enhances 5- fluorouracil cytotoxicity

Giuseppe S A Longo, Julie Izzo, Yu Ming Chang, William P. Tong, Zbigniev Zielinski, Richard Gorlick, Ting Chao Chou, Joseph R. Bertino

Research output: Contribution to journalArticle

36 Citations (Scopus)

Abstract

The cytotoxic effect of sequence and dose of Tomudex (TX) and 5- fluorouracil (FUra) on an HCT-8 colon carcinoma cell line using a clonogenic assay was evaluated. Synergistic cell kill was obtained with 24 h of exposure to TX followed by 4 h of exposure to FUra. Marginal synergy was obtained with the same sequence but with a 5-day exposure to FUra. The reverse sequence, FUra (either 4 h or 5 days), followed by TX (24 h), resulted in less-than- additive cell kill. The synergistic effect was not due to augmented inhibition of thymidylate synthase, as determined by the measurement of thymidylate synthase activity by tritium release from [5-3H]2'-deoxyuridine. Surprisingly, an increase in intracellular levels of phosphoribosylpyrophosphate was observed after 24 h of exposure to TX, suggesting the possibility of an indirect effect of TX and/or its polyglutamates on purine biosynthesis. Moreover, we observed an increased formation of FUra nucleotides in the cells preexposed to TX, likely due to the increased intracellular levels of phosphoribosylpyrophosphate, that as a consequence led to an enhanced incorporation of FUra into RNA and increased cell killing.

Original languageEnglish (US)
Pages (from-to)469-473
Number of pages5
JournalClinical Cancer Research
Volume4
Issue number2
StatePublished - Feb 1998
Externally publishedYes

Fingerprint

Fluorouracil
Colon
Carcinoma
Thymidylate Synthase
Polyglutamic Acid
Deoxyuridine
Tritium
raltitrexed
Nucleotides
RNA
Cell Line

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Longo, G. S. A., Izzo, J., Chang, Y. M., Tong, W. P., Zielinski, Z., Gorlick, R., ... Bertino, J. R. (1998). Pretreatment of colon carcinoma cells with tomudex enhances 5- fluorouracil cytotoxicity. Clinical Cancer Research, 4(2), 469-473.

Pretreatment of colon carcinoma cells with tomudex enhances 5- fluorouracil cytotoxicity. / Longo, Giuseppe S A; Izzo, Julie; Chang, Yu Ming; Tong, William P.; Zielinski, Zbigniev; Gorlick, Richard; Chou, Ting Chao; Bertino, Joseph R.

In: Clinical Cancer Research, Vol. 4, No. 2, 02.1998, p. 469-473.

Research output: Contribution to journalArticle

Longo, GSA, Izzo, J, Chang, YM, Tong, WP, Zielinski, Z, Gorlick, R, Chou, TC & Bertino, JR 1998, 'Pretreatment of colon carcinoma cells with tomudex enhances 5- fluorouracil cytotoxicity', Clinical Cancer Research, vol. 4, no. 2, pp. 469-473.
Longo GSA, Izzo J, Chang YM, Tong WP, Zielinski Z, Gorlick R et al. Pretreatment of colon carcinoma cells with tomudex enhances 5- fluorouracil cytotoxicity. Clinical Cancer Research. 1998 Feb;4(2):469-473.
Longo, Giuseppe S A ; Izzo, Julie ; Chang, Yu Ming ; Tong, William P. ; Zielinski, Zbigniev ; Gorlick, Richard ; Chou, Ting Chao ; Bertino, Joseph R. / Pretreatment of colon carcinoma cells with tomudex enhances 5- fluorouracil cytotoxicity. In: Clinical Cancer Research. 1998 ; Vol. 4, No. 2. pp. 469-473.
@article{16107fa4d897408f932f4e3944f3fc53,
title = "Pretreatment of colon carcinoma cells with tomudex enhances 5- fluorouracil cytotoxicity",
abstract = "The cytotoxic effect of sequence and dose of Tomudex (TX) and 5- fluorouracil (FUra) on an HCT-8 colon carcinoma cell line using a clonogenic assay was evaluated. Synergistic cell kill was obtained with 24 h of exposure to TX followed by 4 h of exposure to FUra. Marginal synergy was obtained with the same sequence but with a 5-day exposure to FUra. The reverse sequence, FUra (either 4 h or 5 days), followed by TX (24 h), resulted in less-than- additive cell kill. The synergistic effect was not due to augmented inhibition of thymidylate synthase, as determined by the measurement of thymidylate synthase activity by tritium release from [5-3H]2'-deoxyuridine. Surprisingly, an increase in intracellular levels of phosphoribosylpyrophosphate was observed after 24 h of exposure to TX, suggesting the possibility of an indirect effect of TX and/or its polyglutamates on purine biosynthesis. Moreover, we observed an increased formation of FUra nucleotides in the cells preexposed to TX, likely due to the increased intracellular levels of phosphoribosylpyrophosphate, that as a consequence led to an enhanced incorporation of FUra into RNA and increased cell killing.",
author = "Longo, {Giuseppe S A} and Julie Izzo and Chang, {Yu Ming} and Tong, {William P.} and Zbigniev Zielinski and Richard Gorlick and Chou, {Ting Chao} and Bertino, {Joseph R.}",
year = "1998",
month = "2",
language = "English (US)",
volume = "4",
pages = "469--473",
journal = "Clinical Cancer Research",
issn = "1078-0432",
publisher = "American Association for Cancer Research Inc.",
number = "2",

}

TY - JOUR

T1 - Pretreatment of colon carcinoma cells with tomudex enhances 5- fluorouracil cytotoxicity

AU - Longo, Giuseppe S A

AU - Izzo, Julie

AU - Chang, Yu Ming

AU - Tong, William P.

AU - Zielinski, Zbigniev

AU - Gorlick, Richard

AU - Chou, Ting Chao

AU - Bertino, Joseph R.

PY - 1998/2

Y1 - 1998/2

N2 - The cytotoxic effect of sequence and dose of Tomudex (TX) and 5- fluorouracil (FUra) on an HCT-8 colon carcinoma cell line using a clonogenic assay was evaluated. Synergistic cell kill was obtained with 24 h of exposure to TX followed by 4 h of exposure to FUra. Marginal synergy was obtained with the same sequence but with a 5-day exposure to FUra. The reverse sequence, FUra (either 4 h or 5 days), followed by TX (24 h), resulted in less-than- additive cell kill. The synergistic effect was not due to augmented inhibition of thymidylate synthase, as determined by the measurement of thymidylate synthase activity by tritium release from [5-3H]2'-deoxyuridine. Surprisingly, an increase in intracellular levels of phosphoribosylpyrophosphate was observed after 24 h of exposure to TX, suggesting the possibility of an indirect effect of TX and/or its polyglutamates on purine biosynthesis. Moreover, we observed an increased formation of FUra nucleotides in the cells preexposed to TX, likely due to the increased intracellular levels of phosphoribosylpyrophosphate, that as a consequence led to an enhanced incorporation of FUra into RNA and increased cell killing.

AB - The cytotoxic effect of sequence and dose of Tomudex (TX) and 5- fluorouracil (FUra) on an HCT-8 colon carcinoma cell line using a clonogenic assay was evaluated. Synergistic cell kill was obtained with 24 h of exposure to TX followed by 4 h of exposure to FUra. Marginal synergy was obtained with the same sequence but with a 5-day exposure to FUra. The reverse sequence, FUra (either 4 h or 5 days), followed by TX (24 h), resulted in less-than- additive cell kill. The synergistic effect was not due to augmented inhibition of thymidylate synthase, as determined by the measurement of thymidylate synthase activity by tritium release from [5-3H]2'-deoxyuridine. Surprisingly, an increase in intracellular levels of phosphoribosylpyrophosphate was observed after 24 h of exposure to TX, suggesting the possibility of an indirect effect of TX and/or its polyglutamates on purine biosynthesis. Moreover, we observed an increased formation of FUra nucleotides in the cells preexposed to TX, likely due to the increased intracellular levels of phosphoribosylpyrophosphate, that as a consequence led to an enhanced incorporation of FUra into RNA and increased cell killing.

UR - http://www.scopus.com/inward/record.url?scp=0031937913&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031937913&partnerID=8YFLogxK

M3 - Article

C2 - 9516938

AN - SCOPUS:0031937913

VL - 4

SP - 469

EP - 473

JO - Clinical Cancer Research

JF - Clinical Cancer Research

SN - 1078-0432

IS - 2

ER -